Literature DB >> 8430777

Multiple metabolic effects of CGRP in conscious rats: role of glycogen synthase and phosphorylase.

L Rossetti1, S Farrace, S B Choi, A Giaccari, L Sloan, S Frontoni, M S Katz.   

Abstract

Calcitonin gene-related peptide (CGRP) is a neuropeptide that is released at the neuromuscular junction in response to nerve excitation. To examine the relationship between plasma CGRP concentration and intracellular glucose metabolism in conscious rats, we performed insulin (22 pmol.kg-1.min-1) clamp studies combined with the infusion of 0, 20, 50, 100, 200, and 500 pmol.kg-1.min-1 CGRP (plasma concentrations ranging from 2 x 10(-11) to 5 x 10(-9) M). CGRP antagonized insulin's suppression of hepatic glucose production at plasma concentrations (approximately 10(-10) M) that are only two- to fivefold its basal portal concentration. Insulin-mediated glucose disposal was decreased by 20-32% when CGRP was infused at 50 pmol.kg-1.min-1 (plasma concentration 3 x 10(-10) M) or more. The impairment in insulin-stimulated glycogen synthesis in skeletal muscle accounted for all of the CGRP-induced decrease in glucose disposal, while whole body glycolysis was increased despite the reduction in total glucose uptake. The muscle glucose 6-phosphate concentration progressively increased during the CGRP infusions. CGRP inhibited insulin-stimulated glycogen synthase in skeletal muscle with a 50% effective dose of 1.9 +/- 0.36 x 10(-10) M. This effect on glycogen synthase was due to a reduction in enzyme affinity for UDP-glucose, with no changes in the maximal velocity. In vitro CGRP stimulated both hepatic and skeletal muscle adenylate cyclase in a dose-dependent manner. These data suggest that 1) CGRP is a potent antagonist of insulin at the level of muscle glycogen synthesis and hepatic glucose production; 2) inhibition of glycogen synthase is its major biochemical action in skeletal muscle; and 3) these effects are present at concentrations of the peptide that may be in the physiological range for portal vein and skeletal muscle. These data underscore the potential role of CGRP in the physiological modulation of intracellular glucose metabolism.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8430777     DOI: 10.1152/ajpendo.1993.264.1.E1

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

1.  Mechanisms of fatty acid-induced inhibition of glucose uptake.

Authors:  G Boden; X Chen; J Ruiz; J V White; L Rossetti
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

2.  Increased epinephrine and skeletal muscle responses to hypoglycemia in non-insulin-dependent diabetes mellitus.

Authors:  H Shamoon; S Friedman; C Canton; L Zacharowicz; M Hu; L Rossetti
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

3.  Different pharmacological characteristics in L6 and C2C12 muscle cells and intact rat skeletal muscle for amylin, CGRP and calcitonin.

Authors:  R A Pittner; D Wolfe-Lopez; A A Young; K Beaumont
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

4.  Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia in diabetes.

Authors:  L Rossetti; A Giaccari; N Barzilai; K Howard; G Sebel; M Hu
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

5.  Skeletal muscle glycogenolysis is more sensitive to insulin than is glucose transport/phosphorylation. Relation to the insulin-mediated inhibition of hepatic glucose production.

Authors:  L Rossetti; M Hu
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

6.  Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus.

Authors:  N Cohen; M Halberstam; P Shlimovich; C J Chang; H Shamoon; L Rossetti
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

7.  In vivo effects of glucosamine on insulin secretion and insulin sensitivity in the rat: possible relevance to the maladaptive responses to chronic hyperglycaemia.

Authors:  A Giaccari; L Morviducci; D Zorretta; P Sbraccia; F Leonetti; S Caiola; A Buongiorno; R C Bonadonna; G Tamburrano
Journal:  Diabetologia       Date:  1995-05       Impact factor: 10.122

Review 8.  Mono and dual agonists of the amylin, calcitonin, and CGRP receptors and their potential in metabolic diseases.

Authors:  Nina Sonne; Morten A Karsdal; Kim Henriksen
Journal:  Mol Metab       Date:  2020-11-07       Impact factor: 7.422

9.  A high carbohydrate diet induces insulin resistance through decreased glucose utilization in ovariectomized rats.

Authors:  Sun Min Park; Chun Hee Park; Jun Dong Wha; Soo Bong Choi
Journal:  Korean J Intern Med       Date:  2004-06       Impact factor: 2.884

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.